Animal models of tourette syndrome

Movement Disorders

Volumn , Issue , 2005, Pages 441-448

  Burke, Kathleen ^a   Lombroso, Paul J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59649104320     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088382-0/50040-2     Document Type: Chapter

References (77)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
2. Alexander G.E. Basal ganglia-thalamocortical circuits: Their role in control of movements. J Clin Neurophysiol 1994, 11:420-431.
3. Anderson G.M., Pollak E.S., Chatterjee D., Leckman J.F., Riddle M.A., Cohen D.J. Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 1992, 58:123-133.
4. Anderson G.M., Pollak E.S., Chatterjee D., Leckman J.F., Riddle M.A., Cohen D.J. Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions. Arch Gen Psychiatry 1992, 49:584-586.
5. Archelos J.J., Hartung H.P. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 2000, 23:317-327.
6. Bessen D.E. Genetics of childhood disorders: XXXII. Autoimmune disorders, part 5: streptococcal in fection and autoimmunity, an epidemiological perspective. J Am Acad Child Adolesc Psychiatry 2001, 40:1346-1348.
7. Black K.J., Gado M.H., Perlmutter J.S. PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function. J Neurosci 1997, 17:3168-3177.
8. Brunn R.D., Budman C.L. The natural history of Tourette syndrone. Adv Neurol 1992, 58:1-6.
9. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by acholeratoxin transgene. Nature 1991, 350:74-77.
10. Butler I.J., Koslow S.H., Seifert W.E., Caprioli R.M., Singer H.S. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979, 6:37-39.
11. Camphell K.M., de Lecea L., Severynse D.M., Caron M.G., Mc Grath M.J., Sparber S.B., Sun L.Y., Burton F.H. OCD-like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+neurons. J Neurosci 1999, 19:5044-5053.
12. Campbell K.M., Rohland R.M., McGrath M.J., Satoskar S.D., Burton F.H. Detecting subtle differences in behavior using waveform display analysis. Physiol Behav 1998, 64:83-91.
13. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
14. Challas G., Chapel J.L., Jenkins R.L. Tourette's disease: Control of symptoms and its clinical course. Int J Neuropsychiatry 1967, 3(Suppl. 1):95-109.
15. Chase T.N., Geoffrey V., Gillespie M., Burrows G.H. Structural and functional studies of Gilles de la Tourette syndrome. Rev Neurol (Paris) 1986, 142:851-855.
16. Cohen D.J., Friedhoff A.J., Leckman J.F., Chase T.N. Tourette syndrome: Extending basic research to clinical care, the clinical phenotype, and natural history. Adv Neurol 1992, 58:341-362.
17. Cohen D.J., Shaywitz B.A., Caparulo B., Young J.G., Bowers M.B. Chronic, multiple tics of Gilles de la Tourette's disease, CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 1978, 35:245-250.
18. Comings D.E. Tourette's Syndrome and Human Behavior 1990, Hope Press, Duarte, California.
19. Comings D.E., Comings B.G. A controlled study of Tourette syndrome. I-VI. Am J Hum Genet 1987, 41:701-838.
20. Creese I., Iversen S.D. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 1973, 55:369-382.
21. Cunningham V.J., Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993, 13:15-23.
22. Dantzer R. Stress, stereotypies and welfare. Behavioural Processes 1991, 25:95-102.
23. Erenberg G., Cruse R.P., Rothner A.D. Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology 1985, 35:1346-1348.
24. Florin S.M., Kuczenski R., Segal D.S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 1994, 654:53-62.
25. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: Illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 2001, 107:107-124.
26. Garner J.P., Mason G.J. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav Brain Res 2002, 136:83-92.
27. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 1990, 87:6912-6916.
28. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831.
29. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: A new hypothesis. Trends Neurosci 2000, 23:S71-S77.
30. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C., Wassermann E.M. Altered cortical excitability in obsessive-compulsive disorder. Neurology 2000, 54:142-147.
31. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 2000, 111:195-202.
32. Hallett M. Physiology of basal ganglia disorders: An overview. Can J Neurol Sci 1993, 20:177-183.
33. Husby G., van de Rijn I., Zabriskie J.B., Abdin Z.H., Williams R.C. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976, 144:1094-1110.
34. Jagger J., Prusoff B.A., Cohen D.J., Kidd K.K., Carbonari C.M., John K. The epidemiology of Tourette syndrome: A pilot study. Schizophr Bull 1982, 8:267-278.
35. Jankovic J., Glaze D.G., Frost J.D. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 1984, 34:688-692.
36. Kelley A.E., Lang C.G., Gauthier A.M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berl) 1988, 95:556-569.
37. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993, 92:39-43.
38. Leckman J.F. Tourette's syndrome. The Lancet 2002, 360:1577-1586.
39. Leckman J.F., Walker D.E., Cohen D.J. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993, 150:98-102.
40. Leckman J.F., Walker D.E., Goodman W.K., Pauls D.L., Cohen D.J. "Just right" perceptions associated with compulsive behaviors in Tourette's syndrome. Am J Psychiatry 1994, 151:675-680.
41. Leckman J.F., Goodman W.K., Anderson G.M., Riddle M.A., Chappell P.B., McSwiggan-Hardin M.T., McDougle C.J., et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995, 12:73-86.
42. Levin B., Duchowny M. Childhood obsessive-compulsive disorder and cingulate epilepsy. Biol Psychiatry 1991, 30:1049-1055.
43. Loiselle C.R., Lee O., Moran T.H., Singer H.S. Striatal microinfusion of Tourette syndrome and PANDAS sera: Failure to induce behavioral changes. Movement Disorders 2003, 19:406-415.
44. Loiselle C.R., Lee O., Moran T.H., Singer H.S. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 2004, 19:390-396.
45. Mason G.J. Stereotypies and suffering. Behavioral Processes 1991, 25:103-115.
46. Mazars G. Criteria for identifying cingulate epilepsy. Epilepsia 1970, 11:41-47.
47. McGrath M.J., Campbell K.M., Parks C.R., Burton F.H. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder. Brain Res 2000, 877:23-30.
48. McKinney W.T. Overview of the past contributions of animal models and their changing place in psychiatry. Semin Clin Neuropsychiatry 2001, 6(1):68-78.
49. McKinney W.T., Gardner R., Barlow G.W., McGuire M.T. Conceptual basis of animal models in psychiatry: a conference summary. Ethology and Sociobiology 1994, 15:369-382.
50. Mercadante M.T., Busatto G.F., Lombroso P.J., Prado L., Rosario-Campos M.C., do Valle R., Marques-Dias M.J., et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry 2000, 157:2036-2038.
51. Mink J.W. Basal ganglia dysfunction in Tourette's syndome: A new hypothesis. Pediatr Neurol 2001, 25:190-198.
52. Nordstrom E.J., Burton F.H. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 2002, 7:617-625.
53. Nordstrom E.J., Burton F.H. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 2002, 7:524.
54. Overall K.L. Natural animal models of human psychiatric conditions: Assessment of mechanism and validity. Prog Neuropsychopharmacol Biol Psychiatry 2000, 24:727-776.
55. Pauls D.L., Raymond C., Stevenson J., Leckman J.F. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991, 48:154-163.
56. Pauls D.L., Towbin K.E., Leckman J.F., Zahner G., Cohen D.J. Giles de la Tourette's syndrome and obsessive-compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986, 43:1180-1182.
57. Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. The Lancet 1999, 354:1153-1158.
58. Randrup A., Munkvad I. Pharmacology and physiology of stereotyped behavior. J Psychiatr Res 1974, 11:1-10.
59. Randrup A., Munkvad I., Udsen P. Adrenergic Mechanisms and Amphetamine Induced Abnormal Behaviour. Acta pharmac of Toxicol (Copenh) 1963, 20:145-157.
60. Rebec G.V. Auto- and postsynaptic dopamine receptors in the central nervous system. Monogr Neural Sci 1984, 10:207-223.
61. Ridley R.M. The psychology of perseverative and stereotyped behaviour. Progress in Neurobiology 1994, 44:221-231.
62. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
63. Selling L. The role of infection in the etiology of tics. Arch Neurol Psychiatry 1929, 22:1163-1171.
64. Shapiro A.K., Shapiro E.S., Young J.G., Feinberg T.E. History of Tourette and tic dosorders. Gilles de la Tourette Syndrome 1988, 1-27. Raven Press, New York. A.K. Shapiro, J.G. Young, T.E. Feinberg (Eds.).
65. Shapiro E., Shapiro A.K., Fulop G., Hubbard M., Mandeli J., Nordlie J., Phillips R.A. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989, 46:722-730.
66. Singer H.S., Wendlandt J.T. Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol 2001, 85:163-178.
67. Singer H.S., Tune L.E., Butler I.J., Zaczek R., Coyle J.T. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome. Adv Neurol 1982, 35:177-183.
68. Sweet R.D., Bruun R., Shapiro E., Shapiro A.K. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry 1974, 31:857-861.
69. Swedo S.E., Leonard H.L. Childhood movement disorders and obsessive compulsive disorder. J Clin Psychiatry 1994, 55(Suppl):32-37.
70. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Dow S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264-271.
71. Swerdlow N.R., Leckman J.F. Tourette Syndrome and Related Tic Disorders. Neuropsychopharmacology: The Fifth Generation of Progress 2002, Williams & Wilkins, Lippincott, Philadelphia, PA. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
72. Taylor J.R., Morshed S.A., Parveen S., Mercadante M.T., Scahill L., Peterson B.S., King R.A., et al. An animal model of Tourette's syndrome. Am J Psychiatry 2002, 159:657-660.
73. Van Ameringen M., Mancini C., Oakman J.M., Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999, 56:219-226.
74. Weeks R.A., Turjanski N., Brooks D.J. Tourette's syndrome: A disorder of cingulate and orbitofrontal function?. Q J M 1996, 89:401-408.
75. Wilner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiat 1986, 10:677-690.
76. Wurbel H. Ideal homes? Housing effects on rodent brain and behavior. Trends Neurosci 2001, 24:207-211.
77. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation. Am J Psychiatry 1997, 154.